Roselli M - Search Results

1

Pathological classification of DCIS and planning of therapeutic management.

Buonomo O, Orsaria P, Contino G, Varvaras D, Gioia A, Bonanno E, Pistolese C, Cossu E, Perretta T, Schillaci O, Del Monte G, Roselli M, Mineo TC, Petrella G. Buonomo O, et al. Among authors: roselli m. Anticancer Res. 2009 May;29(5):1499-506. Anticancer Res. 2009. PMID: 19443357 Free article.

2

Monoclonal antibodies in the management of carcinoma patients.

Roselli M, Casciani CU, Guadagni F, Buonomo O, Iorio B, Diodati A, Vittorini V, Greiner JW, Colcher D, Schlom J. Roselli M, et al. Med Oncol Tumor Pharmacother. 1991;8(4):223-8. doi: 10.1007/BF02987190. Med Oncol Tumor Pharmacother. 1991. PMID: 1820487 Review.

3

Clinical value of radiolabeled monoclonal antibodies in the management of carcinoma patients.

Roselli M, Guadagni F, Buonomo O, Lombardo A, Diodati A, Vittorini V, Belardi A, Cipriani C, Casciani CU. Roselli M, et al. In Vivo. 1993 Nov-Dec;7(6B):615-21. In Vivo. 1993. PMID: 8193282 Review.

4

Systemic administration of recombinant interferon alfa in carcinoma patients upregulates the expression of the carcinoma-associated antigens tumor-associated glycoprotein-72 and carcinoembryonic antigen.

Roselli M, Guadagni F, Buonomo O, Belardi A, Vittorini V, Mariani-Costantini R, Greiner JW, Casciani CU, Schlom J. Roselli M, et al. J Clin Oncol. 1996 Jul;14(7):2031-42. doi: 10.1200/JCO.1996.14.7.2031. J Clin Oncol. 1996. PMID: 8683233

5

Intraoperative radioimmunolocalization of an anti-CEA MAb F(Ab')2 (FO23C5) in CEA serum-negative colorectal cancer patients.

Roselli M, Guadagni F, Buonomo O, Belardi A, Vittorini V, Cavazzana A, Spagnoli LG, Cipriani C, Casciani CU. Roselli M, et al. Anticancer Res. 1996 Mar-Apr;16(2):883-9. Anticancer Res. 1996. PMID: 8687145

6

Tumor markers as targets for selective diagnostic and therapeutic procedures.

Roselli M, Guadagni F, Buonomo O, Belardi A, Ferroni P, Diodati A, Anselmi D, Cipriani C, Casciani CU, Greiner J, Schlom J. Roselli M, et al. Anticancer Res. 1996 Jul-Aug;16(4B):2187-92. Anticancer Res. 1996. PMID: 8694541 Review.

7

Clinical utility of CA 72-4 serum marker in the staging and immediate post-surgical management of gastric cancer patients.

Spila A, Roselli M, Cosimelli M, Ferroni P, Cavaliere F, Arcuri R, Tedesco M, Carlini S, D'Alessandro R, Perri P, Casciani CU, Greiner JW, Schlom J, Guadagni F. Spila A, et al. Among authors: roselli m. Anticancer Res. 1996 Jul-Aug;16(4B):2241-7. Anticancer Res. 1996. PMID: 8694550

8

Novel clinical approaches in monoclonal antibody-based management in colorectal cancer patients: radioimmunoguided surgery and antigen augmentation.

Roselli M, Buonomo O, Piazza A, Guadagni F, Vecchione A, Brunetti E, Cipriani C, Amadei G, Nieroda C, Greiner JW, Casciani CU. Roselli M, et al. Semin Surg Oncol. 1998 Dec;15(4):254-62. doi: 10.1002/(sici)1098-2388(199812)15:4<254::aid-ssu14>3.0.co;2-v. Semin Surg Oncol. 1998. PMID: 9829383 Review.

9

Postoperative adjuvant therapy for stage IB non-small-cell lung cancer.

Mineo TC, Ambrogi V, Corsaro V, Roselli M. Mineo TC, et al. Among authors: roselli m. Eur J Cardiothorac Surg. 2001 Aug;20(2):378-84. doi: 10.1016/s1010-7940(01)00779-5. Eur J Cardiothorac Surg. 2001. PMID: 11463561 Clinical Trial.

10

Radioguided-surgery of early breast lesions.

Buonomo O, Cabassi A, Guadagni F, Piazza A, Felici A, Piccirillo R, Atzei GP, Cipriani C, Schiaroli S, Mariotti S, Guazzaroni MN, Cossu E, Simonetti G, Pernazza E, Casciani CU, Roselli M. Buonomo O, et al. Among authors: roselli m. Anticancer Res. 2001 May-Jun;21(3C):2091-7. Anticancer Res. 2001. PMID: 11501831 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

375 results

Search Page

Filters